Unsafe injecting practices, blood exchange, the use of nonsterile needles, and other cutting instruments for tattooing are common in correctional institutions, resulting in a number of blood transmitted infections. A mathematical model for assessing the dynamics of HCV and HIV coinfection within correctional institutions is proposed and comprehensively analyzed. The HCV-only and HIV-only submodels are first considered. Analytical expressions for the threshold parameter in each submodel and the cointeraction are derived. Global dynamics of this coinfection shows that whenever the threshold parameter for the respective submodels and the coinfection model is less than unity, then the epidemics die out, the reverse condition implies disease persistence within correctional institutions. Numerical simulations using a set of plausible parameter values are provided to support analytical findings. 1. Introduction Prior studies suggests that prevalence of both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections is known to be higher among incarcerated populations than the general population, since a high proportion of incarcerated individuals originate from high-risk environments and have high-risk behaviors, especially drug use [1–6]. HCV and HIV coinfections represent a public health problem of growing importance; because of similar modes of spread, many people are coinfected with HCV and HIV or HCV and HBV and in some cases with all three viruses at the same time [5]. In particular, HCV/HIV coinfections are common and are known as “twin epidemics” [6, 7]. Both HIV and HIV are blood born RNA (ribonucleic acid) viruses that replicate rapidly. Unsafe injecting practices, blood exchange and the use of non-sterile needles are the most efficient means of transmitting both viruses [6, 8]. Correctional institutions host a disproportionately high prevalence of HCV infection and coinfections. The prevalence of HCV among prisoners approaches 57.5% and far exceeds that of HIV in prison [9, 10]. Transmission of these infections is believed to be a rare consequence of blood or body fluid exposures in the prison. However, if transmission does occur, the consequences are permanent and potentially fatal [5–7]. Coinfection with the two viruses (HCV/HIV) is associated with an accelerated course of hepatitis C disease [5–7]. Prison populations constitute a very high-risk group; they have high levels of HCV infection and HIV or HBV coinfection [11, 12]. HCV positive inmates are at exceptional risk for coinfection with HIV because of the association of
References
[1]
Canadian HIV/AIDS Legal Network, “HIV and hepatitis C in prison,” 2008.
[2]
K. V. Dumchev, R. Soldyshev, H. Z. Qian et al., “HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey,” Harm Reduction Journal, vol. 6, article 23, 2009.
[3]
C. Aceijas and T. Rhodes, “Global estimates of prevalence of HCV infection among injecting drug users,” International Journal of Drug Policy, vol. 18, no. 5, pp. 352–358, 2007.
[4]
E. F. White, R. S. Garfein, K. C. Brouwer et al., “Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.,” Salud Publica de Mexico, vol. 49, no. 3, pp. 165–172, 2007.
[5]
K. A. Hennessey, A. A. Kim, V. Griffin, N. T. Collins, C. M. Weinbaum, and K. Sabin, “Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States,” Journal of Urban Health, vol. 86, no. 1, pp. 93–105, 2009.
[6]
E. Pontali and F. Ferrari, “Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus,” International Journal of Prisoner Health, vol. 4, no. 2, pp. 77–82, 2008.
[7]
G. E. Macalino, D. Dhawan, and J. D. Rich, “A missed opportunity: hepatitis C screening of prisoners,” American Journal of Public Health, vol. 95, no. 10, pp. 1739–1740, 2005.
[8]
M. F. Vescio, B. Longo, S. Babudieri et al., “Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis,” Journal of Epidemiology and Community Health, vol. 62, no. 4, pp. 305–313, 2008.
[9]
M. E. Hellard, J. S. Hocking, and N. Crofts, “The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities,” Epidemiology and Infection, vol. 132, no. 3, pp. 409–415, 2004.
[10]
M. S. E. Anwar, M. Nafees, and U. Nabi, “Sero-prevalence of HCV and associated infections with HIV and HBV among prisoners in Lahore,” Biomedica, vol. 27, no. 2, pp. 119–1122, 2011.
[11]
A. A. Adjei, H. B. Armah, F. Gbagbo et al., “Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study,” Journal of Medical Microbiology, vol. 56, no. 3, pp. 391–397, 2007.
[12]
T. Guimar？es, C. F. Granato, D. Varella, M. L. Ferraz, A. Castelo, and E. G. Kallás, “High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection,” The Brazilian Journal of Infectious Diseases, vol. 5, no. 3, pp. 111–118, 2001.
[13]
R. M. M. Anderson, Infectious Diseases of Humans, Dynamics and Control, Oxford University Press, 1991.
[14]
N. Bailey, The Mathematical Theory of Infectious Diseases, Charles Griffin, 1975.
[15]
F. Brauer and C. Castillo-Chávez, Mathematical Models in Population Biology and Epidemiology, Springer, 2001.
[16]
H. W. Hethcote, “Mathematics of infectious diseases,” SIAM Review, vol. 42, no. 4, pp. 599–653, 2000.
[17]
P. Van Den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,” Mathematical Biosciences, vol. 180, pp. 29–48, 2002.
[18]
D. J. Daley and J. Gani, Epidemic Modelling: An Introduction, vol. 15, Cambridge University Press, Cambridge, UK, 1999.
[19]
S. Mushayabasa and C. P. Bhunu, “Modeling HIV transmission dynamics among male prisoners in Sub-Saharan Africa,” International Journal of Applied Mathematics, vol. 41, no. 1, pp. 62–67, 2011.
[20]
E. Kajita, J. T. Okano, E. N. Bodine, S. P. Layne, and S. Blower, “Modelling an outbreak of an emerging pathogen,” Nature Reviews Microbiology, vol. 5, no. 9, pp. 700–709, 2007.
[21]
A. A. Adjei, H. B. Armah, F. Gbagbo et al., “Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study,” Journal of Medical Microbiology, vol. 56, no. 3, pp. 391–397, 2007.
[22]
E. Gough, M. C. Kempf, L. Graham et al., “HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis,” BMC Public Health, vol. 10, article 777, 2010.
[23]
B. H. McGovern, A. Wurcel, A. Y. Kim et al., “Acute hepatitis C virus infection in incarcerated injection drug users,” Clinical Infectious Diseases, vol. 42, no. 12, pp. 1663–1670, 2006.
[24]
S. Mushayabasa, C. P. Bhunu, and R. J. Smith, “Assessing the impact of educational campaigns on controlling HCV among women in prison settings,” Communications in Nonlinear Science and Numerical Simulation, vol. 17, no. 4, pp. 1714–1724, 2012.
[25]
J. C. Kamgang and G. Sallet, “Computation of threshold conditions for epidemiological models and global stability of the disease-free equilibrium (DFE),” Mathematical Biosciences, vol. 213, no. 1, pp. 1–12, 2008.
[26]
S. Mushayabasa and C. P. Bhunu, “Is HIV infection associated with an increased risk for cholera? Insights from a mathematical model,” Biosystems, vol. 109, pp. 203–213, 2012.
[27]
S. Mushayabasa CP Bhunu, “Assessing the impact of increasing antimicrobial resistance of Vibro cholerae on the future trends of cholera epidemic,” ISRN Biomathematics. In press.
[28]
A. Berman and R. J. Plemmons, “Nonnegative matrice in the mathematical sciences,” SIAM Review, vol. 35, pp. 43–79, 1993.
[29]
Y. Kuang, Delay Differential Equations with Applications in Population Dynamics, vol. 191, Academic Press, Boston, Mass, USA, 1993.
[30]
Y. Xiao and L. Chen, “Modeling and analysis of a predator-prey model with disease in the prey,” Mathematical Biosciences, vol. 171, no. 1, pp. 59–82, 2001.
[31]
J. Hofbauer and K. Sigmund, The Theory of Evolution and Dynamical Systems, vol. 7, Cambridge University Press, Cambridge, UK, 1988.
[32]
J. P. LaSalle, The Stability of Dynamical Systems, vol. 25 of CBMS-NSF Regional Conference Series in Applied 398 Mathematics, Society for Industrial and Applied Mathematics, Philadelphia, Pa, USA, 1976.
[33]
L. Perko, Differential Equations and Dynamical Systems, vol. 7 of Text in Applied Mathematics, Springer, Berlin, Germany, 2000.
[34]
J. C. Helton, “Uncertainty and sensitivity analysis techniques for use in performance assessment for radioactive waste disposal,” Reliability Engineering and System Safety, vol. 42, no. 2-3, pp. 327–367, 1993.
[35]
A. Saltelli, Sensitivity Analysis, John Wiley & Sons, Chichester, UK, 2000.
[36]
A. Mubayi, P. Greenwood, X. Wang et al., “Types of drinkers and drinking settings: an application of a mathematical model,” Addiction, vol. 106, no. 4, pp. 749–758, 2011.
[37]
M. Samsuzzoha and S. M. Lucy, “Uncertainty and sensitivity analysis of the basic reproductive number of a vaccinated epidemic model of influenza,” Applied Mathematical Modelling, vol. 145, no. 12, pp. 1127–1137, 1997.
[38]
C. P. Bhunu, S. Mushayabasa, and R. J. Smith, “Assessing the effects of poverty in tuberculosis transmission dynamics,” Applied Mathematical Modelling, vol. 36, no. 9, pp. 4173–4185, 2012.
[39]
S. M. Blower and H. Dowlatabadi, “Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example,” International Statistical Review, vol. 2, pp. 229–243, 1994.
[40]
Incarceration is not an equal opportunity punishment, http://www.prisonpolicy.org.
[41]
C. P. Bhunu and S. Mushayabasa, “Assessing the effects of intravenous drug use on hepatitis C transmission dynamics,” Journal of Biological Systems, vol. 19, no. 3, pp. 447–460, 2011.
[42]
P. Vickerman, M. Hickman, and A. Judd, “Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study,” International Journal of Epidemiology, vol. 36, no. 2, pp. 396–405, 2007.
[43]
K. Dolan, A. Wodak, and R. Penny, “AIDS behind bars: preventing HIV spread among incarcerated drug injectors,” AIDS, vol. 9, no. 8, pp. 825–832, 1995.
[44]
L. Arriola and J. Hyman, Lecture notes, forward and adjoint sensitivity analysis: with applications in Dynamical Systems, Linear Algebra and Optimisation Mathematical and Theoretical Biology 414 Institute, Summer, 2005.
[45]
A. Korobeinikov, “Lyapunov functions and global stability for SIR and SIRS epidemiological models with non-linear transmission,” Bulletin of Mathematical Biology, vol. 68, no. 3, pp. 615–626, 2006.
[46]
S. Mushayabasa, C. P. Bhunu, C. Webb, and M. Dhlamini, “A mathematical model for assessing the impact of poverty on yaws eradication,” Applied Mathematical Modelling, vol. 36, no. 4, pp. 1653–1667, 2012.
[47]
A. H. M. Alizadeh, S. M. Alavian, K. Jafari, and N. Yazdi, “Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan—Iran,” World Journal of Gastroenterology, vol. 11, no. 26, pp. 4085–4089, 2005.
